News and Trends 14 Dec 2022
PhoreMost and ThinkCyte collaborate on AI-based drug discovery
PhoreMost Ltd. and ThinkCyte K.K have announced a strategic research partnership aimed at advancing modern phenotypic drug screening using artificial intelligence (AI). The partnership leverages both companies’ technologies in high-throughput…